CareLit Fachartikel

An Open-Label Extension (OLE) study of Tezacaftor/Ivacaftor (TEZ/IVA) in patients (PTS) ≥ 12 years with cystic fibrosis (CF) Homozygous for F508DEL-CFTR (F/F) or Heterozygous for…

P Flume, R Fischer Biner, DG Downey, C Brown, M Jain, R Fischer, C de Boeck, D Campbell, X Wang, N Ahluwalia, CA Owen, C Wainwright · Pneumologie · 2020 · Heft S 01 S 01

Dokument
1214521
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
P Flume, R Fischer Biner, DG Downey, C Brown, M Jain, R Fischer, C de Boeck, D Campbell, X Wang, N Ahluwalia, CA Owen, C Wainwright
Ausgabe
Heft S 01 S 01 / 2020
Jahrgang 74
Seiten
–
Erschienen: 2020-03-01 00:00:00
ISSN
0934-8387
DOI
10.1055/s-0039-3403253

Zusammenfassung

An Open-Label Extension (OLE) study of Tezacaftor/Ivacaftor (TEZ/IVA) in patients (PTS) ≥ 12 years with cystic fibrosis (CF) Homozygous for F508DEL-CFTR (F/F) or Heterozygous for F508DEL-CFTR and a residual function mutation (F/RF)

Schlagworte

F508Del-Cftr Open-Label Extension Study Tezacaftor Ivacaftor Patients Years Cystic Fibrosis Homozygous Heterozygous Pneumologie